In this video, Motley Fool health-care analyst David Williamson takes a look at Threshold's (NASDAQ:THLD) big week and the news on Friday that has shares soaring even higher. Find out what it means for investors in Threshold and competitor Celgene if MAESTRO is a success.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.